Medication info
Gaba New Extended-Release Tablet 75mg (Pregabalin)

Gaba New Extended-Release Tablet 75mg (Pregabalin)

Prescription medicationTablet
Ingredient · strength
Pregabalin›42mg / 1 tablet
Manufacturer / importer
한림제약(주)
Appearance
This medication is a white to pale yellow, oblong, film-coated extended-release tablet.
Packaging
30 tablets/PTP [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202401342 · Approved 2024.05.29 · Insurance code 645307080

Summary

Main use
Relief of peripheral neuropathic pain
Who uses it
Adults · Children
Adult dosage
This medication is administered once daily after the evening meal. It should be swallowed whole and not divided, crushed, or chewed. The starting dose for adults is 150mg (1 tablet) once daily, and it may be increased to a maximum of 600mg per day in intervals of one week based on each patient's response and tolerability. In cases of impaired renal function, dosage adjustments should be made based on creatinine clearance (CLcr), for example, CL
Children's dosage
The safety and efficacy of this medication in patients under 19 years have not been established.

Ingredients

Manufacturer
한림제약(주)

Efficacy & effects

Relief of peripheral neuropathic pain

  • Peripheral neuropathic pain
View approved original text

This medication is used to relieve pain caused by peripheral neuropathy in adults. It helps to reduce pain resulting from nerve damage, thereby improving the quality of life for patients. By alleviating pain, it assists in minimizing discomfort during daily activities and promoting a more comfortable state. Thus, it is effective for the treatment of peripheral neuropathic pain.

Dosage and Administration

Adult dosage

This medication is administered once daily after the evening meal. It should be swallowed whole and not divided, crushed, or chewed. The starting dose for adults is 150mg (1 tablet) once daily, and it may be increased to a maximum of 600mg per day in intervals of one week based on each patient's response and tolerability. In cases of impaired renal function, dosage adjustments should be made based on creatinine clearance (CLcr), for example, CL

Children's dosage

The safety and efficacy of this medication in patients under 19 years have not been established.

Precautions

This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or symptoms of depression occur during treatment, it is important to consult a doctor immediately. Patients with hypersensitivity to this medication should not take it. Diabetic patients may experience weight gain after taking this medication, which may require adjustments to their blood glucose control medications. If allergic reactions such as angioedema occur, the medication should be discontinued immediately, and healthcare professionals should be informed. Elderly patients must be especially careful at the beginning of treatment due to the risk of dizziness or drowsiness that may lead to falls. Transient blurred vision or changes in eyesight may occur; consult a doctor if any unusual symptoms arise. Discontinuation of this medication suddenly may cause withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually according to a doctor's instructions. Due to the risk of drug abuse, patients with a history of substance misuse should use this medication cautiously. Patients with impaired kidney function may require dose adjustments. Patients with cardiovascular diseases should consult a doctor before use. Caution is advised when using this medication with opioid analgesics, as it may increase the central nervous system depressant effects. Patients with respiratory or neurological diseases, and elderly individuals may be at risk of severe respiratory depression and might need dose adjustments. Pregnant women should avoid this medication, especially in early pregnancy, due to the risk of fetal malformations, unless under special circumstances, and women of childbearing age should use effective contraceptive methods. Side effects such as dizziness, drowsiness, weight gain, and constipation may occur during use, so caution is advised. It is advisable to avoid hazardous activities such as driving or operating machinery until symptoms stabilize after taking this medication. Severe skin reactions may rarely occur; if any skin abnormalities arise, the medication should be discontinued immediately and healthcare professionals consulted. This medication has minimal interactions with other drugs; however, caution is advised when used with central nervous system depressants, as it may increase side effects. Breastfeeding women should consult a doctor before using this medication, as it may be transmitted through breast milk, prompting a choice between stopping the medication or breastfeeding. In cases of overdose, symptoms may include confusion, drowsiness, depression, and seizures, requiring immediate emergency treatment. Keep this medication out of reach of children, and be careful not to transfer it into other containers.

Side effects and when to seek care immediately

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, abnormal vision, paralysis, urination abnormalities

Mild side effects

  • Dizziness
  • drowsiness
  • headache
  • lethargy
  • somnolence
  • constipation
  • dyspepsia
  • nausea
  • dry mouth
  • vomiting
Show 24 more
  • abdominal distension
  • weight gain
  • increased blood creatine phosphokinase
  • bradycardia
  • palpitations
  • blurred vision
  • itching
  • arthralgia
  • hypoglycemia
  • rhinitis
  • hypertension
  • snoring
  • oral sensory loss
  • excessive salivation
  • gastroesophageal reflux
  • ascites
  • dysphagia
  • pancreatitis
  • sweating
  • rash
  • cold sweat
  • muscle cramps
  • joint swelling
  • myalgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1°C and 30°C at room temperature to preserve its effectiveness.

Appearance and packaging

Appearance

This medication is a white to pale yellow, oblong, film-coated extended-release tablet.

Package unit

30 tablets/PTP [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.